Shares of Sarepta Therapeutic (NASDAQ: SRPT) have more than doubled Tuesday following strong trial results, but according to analysts at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE